News
FDA Grants Breakthrough Therapy Designation to Investigational Drug Adrabetadex for Individuals with Infantile-Onset Niemann-Pick Disease Type C
December 9, 2025
Press Release
Data Analyses Show Benefit for Individuals With Infantile-Onset Niemann-Pick Disease Type C Treated With Investigational Drug Adrabetadex
October 9, 2025
Press Release
Mandos Health to Present New Analyses in Niemann-Pick Disease Type C at the 2025 American Neurological Association Annual Meeting
September 12, 2025
Press Release
Roquette Announces Strategic Investment and Innovation Agreement with Beren Therapeutics P.B.C.
May 23, 2023
Press Release